140 related articles for article (PubMed ID: 26317795)
1. Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.
Liu J; Li F; Ping Y; Wang L; Chen X; Wang D; Cao L; Zhao S; Li B; Kalinski P; Thorne SH; Zhang B; Zhang Y
Oncotarget; 2015 Sep; 6(28):24978-89. PubMed ID: 26317795
[TBL] [Abstract][Full Text] [Related]
2. T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).
Olsnes AM; Motorin D; Ryningen A; Zaritskey AY; Bruserud Ø
Cancer Immunol Immunother; 2006 Jul; 55(7):830-40. PubMed ID: 16267679
[TBL] [Abstract][Full Text] [Related]
3. Priming a vascular-selective cytokine response permits CD8
Kim DJ; Anandh S; Null JL; Przanowski P; Bhatnagar S; Kumar P; Shelton SE; Grundy EE; Chiappinelli KB; Kamm RD; Barbie DA; Dudley AC
Nat Commun; 2023 Apr; 14(1):2122. PubMed ID: 37055433
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of vitiligo patients and relationship with immuno-inflammatory markers.
Mascarenhas MRM; Oliveira MC; Oliveira LF; Magalhães AS; Machado PRL
An Bras Dermatol; 2024; 99(2):196-201. PubMed ID: 37985303
[TBL] [Abstract][Full Text] [Related]
5. Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
Muthuswamy R; Corman JM; Dahl K; Chatta GS; Kalinski P
Prostate; 2016 Sep; 76(12):1095-105. PubMed ID: 27199259
[TBL] [Abstract][Full Text] [Related]
6. Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies.
Rojas JJ; Sampath P; Bonilla B; Ashley A; Hou W; Byrd D; Thorne SH
Cell Rep; 2016 Apr; 15(2):264-73. PubMed ID: 27050526
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
[TBL] [Abstract][Full Text] [Related]
8. Th17 cells inhibit CD8
Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
[TBL] [Abstract][Full Text] [Related]
9. CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency.
Li F; Sheng Y; Hou W; Sampath P; Byrd D; Thorne S; Zhang Y
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32098828
[TBL] [Abstract][Full Text] [Related]
10. Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice.
Collier JL; Pauken KE; Lee CAA; Patterson DG; Markson SC; Conway TS; Fung ME; France JA; Mucciarone KN; Lian CG; Murphy GF; Sharpe AH
J Exp Med; 2023 Oct; 220(10):. PubMed ID: 37432393
[TBL] [Abstract][Full Text] [Related]
11. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Aldinucci D; Casagrande N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
[TBL] [Abstract][Full Text] [Related]
13. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
Nagarsheth N; Wicha MS; Zou W
Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of host immunity in breast cancer: from TILs to the clinic.
Savas P; Salgado R; Denkert C; Sotiriou C; Darcy PK; Smyth MJ; Loi S
Nat Rev Clin Oncol; 2016 Apr; 13(4):228-41. PubMed ID: 26667975
[TBL] [Abstract][Full Text] [Related]
15. Exercise accelerates recruitment of CD8
Miao SN; Chai MQ; Liu XY; Wei CY; Zhang CC; Sun NN; Fei QZ; Peng LL; Qiu H
BMC Cancer; 2024 Apr; 24(1):474. PubMed ID: 38622609
[TBL] [Abstract][Full Text] [Related]
16. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
[TBL] [Abstract][Full Text] [Related]
17. Serpine1 mRNA confers mesenchymal characteristics to the cell and promotes CD8+ T cells exclusion from colon adenocarcinomas.
Polo-Generelo S; Rodríguez-Mateo C; Torres B; Pintor-Tortolero J; Guerrero-Martínez JA; König J; Vázquez J; Bonzón-Kulichenco E; Padillo-Ruiz J; de la Portilla F; Reyes JC; Pintor-Toro JA
Cell Death Discov; 2024 Mar; 10(1):116. PubMed ID: 38448406
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy.
Choi D; Gonzalez-Suarez AM; Dumbrava MG; Medlyn M; de Hoyos-Vega JM; Cichocki F; Miller JS; Ding L; Zhu M; Stybayeva G; Gaspar-Maia A; Billadeau DD; Ma WW; Revzin A
Adv Sci (Weinh); 2024 Feb; 11(5):e2303088. PubMed ID: 38018486
[TBL] [Abstract][Full Text] [Related]
19. Systematic identification of gene combinations to target in innate immune cells to enhance T cell activation.
Xia L; Komissarova A; Jacover A; Shovman Y; Arcila-Barrera S; Tornovsky-Babeay S; Jaya Prakashan MM; Nasereddin A; Plaschkes I; Nevo Y; Shiff I; Yosefov-Levi O; Izhiman T; Medvedev E; Eilon E; Wilensky A; Yona S; Parnas O
Nat Commun; 2023 Oct; 14(1):6295. PubMed ID: 37813864
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
